Search hospitals > New York > New York
Memorial Sloan Kettering Cancer Center
Claim this profileNew York, New York 10065
Global Leader in Breast Cancer
Global Leader in Lymphoma
Conducts research for Cancer
Conducts research for Parotid Gland Cancer
Conducts research for Solid Tumors
4169 reported clinical trials
427 medical researchers
Summary
Memorial Sloan Kettering Cancer Center is a medical facility located in New York, New York. This center is recognized for care of Breast Cancer, Lymphoma, Cancer, Parotid Gland Cancer, Solid Tumors and other specialties. Memorial Sloan Kettering Cancer Center is involved with conducting 4,169 clinical trials across 1,786 conditions. There are 427 research doctors associated with this hospital, such as Christopher J. Forlenza, Thomas Kaley, MD, Nancy Lee, MD, and Andrea Cercek, MD.Area of expertise
1Breast Cancer
Global LeaderStage IV
Stage III
HER2 negative
2Lymphoma
Global LeaderStage IV
Stage II
Stage III
Top PIs
Christopher J. ForlenzaMemorial Sloan Kettering Cancer Center8 years of reported clinical research
Expert in Lymphoma
Expert in Histiocytic Disorders
18 reported clinical trials
38 drugs studied
Thomas Kaley, MDMemorial Sloan Kettering Cancer Center6 years of reported clinical research
Expert in Brain Tumor
Studies Glioblastoma
15 reported clinical trials
23 drugs studied
Nancy Lee, MDMemorial Sloan Kettering Cancer Center2 years of reported clinical research
Studies Squamous Cell Carcinoma
Studies Parotid Gland Cancer
15 reported clinical trials
32 drugs studied
Andrea Cercek, MDMemorial Sloan Kettering Cancer Center2 years of reported clinical research
Studies Colorectal Cancer
Studies Rectal Cancer
15 reported clinical trials
32 drugs studied
Clinical Trials running at Memorial Sloan Kettering Cancer Center
Esophageal Adenocarcinoma
Esophageal Carcinoma
Lung Cancer
Breast Cancer
Ovarian Cancer
Gastroesophageal Junction Adenocarcinoma
Skin Cancer
Parotid Gland Cancer
Esophageal cancer
Multiple Myeloma
Proton Therapy vs Photon Radiation
for Esophageal Cancer
This trial studies how well proton beam radiation therapy compared with intensity modulated photon radiotherapy works in treating patients with stage I-IVA esophageal cancer. Proton beam radiation therapy uses a beam of protons (rather than x-rays) to send radiation inside the body to the tumor without damaging much of the healthy tissue around it. Intensity modulated photon radiotherapy uses high-energy x-rays to deliver radiation directly to the tumor without damaging much of the healthy tissue around it. It is not yet known whether proton beam therapy or intensity modulated photon radiotherapy will work better in treating patients with esophageal cancer.
Recruiting2 awards Phase 31 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Memorial Sloan Kettering Cancer Center?
Where is Memorial Sloan Kettering Cancer Center located?
Who should I call to ask about financial aid or insurance network?
What insurance does Memorial Sloan Kettering Cancer Center accept?
What awards or recognition has Memorial Sloan Kettering Cancer Center received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.